ABROCITINIB vs ACALABRUTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ABROCITINIB vs ACALABRUTINIB: Safety Overview
| Metric | ABROCITINIB | ACALABRUTINIB |
|---|---|---|
| Total FAERS Reports | 3,170 | 9,688 |
| Deaths Reported | 57 | 2,239 |
| Death Rate | 1.8% | 23.1% |
| Hospitalizations | 329 | 2,441 |
| Average Patient Age | 48.5 yrs | 73.2 yrs |
| % Female Patients | 53.9% | 36.8% |
| FDA Approval Date | Jan 14, 2022 | Aug 3, 2022 |
| Manufacturer | U.S. Pharmaceuticals | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |